Title |
Emerging Roles of Glycogen Synthase Kinase 3 in the Treatment of Brain Tumors
|
---|---|
Published in |
Frontiers in Molecular Neuroscience, January 2011
|
DOI | 10.3389/fnmol.2011.00047 |
Pubmed ID | |
Authors |
Caroline N. Mills, Somaira Nowsheen, James A. Bonner, Eddy S. Yang |
Abstract |
The constitutively active protein glycogen synthase kinase 3 (GSK3), a serine/threonine kinase, acts paradoxically as a tumor suppressor in some cancers while potentiates growth in others. Deciphering what governs its actions is vital for understanding many pathological conditions, including brain cancer. What are seemingly disparate roles of GSK3 stems from the complex regulation of many cellular functions by GSK3. This review focuses on the regulation of GSK3, its role in survival, apoptosis and DNA damage, and finally its potential therapeutic impact in brain cancer. A thorough understanding of this versatile protein is critical for improving the outcome of various diseases, especially cancer. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 2% |
Unknown | 55 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 10 | 18% |
Student > Bachelor | 10 | 18% |
Student > Master | 8 | 14% |
Student > Ph. D. Student | 5 | 9% |
Professor > Associate Professor | 5 | 9% |
Other | 7 | 13% |
Unknown | 11 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 16 | 29% |
Biochemistry, Genetics and Molecular Biology | 13 | 23% |
Medicine and Dentistry | 8 | 14% |
Chemistry | 4 | 7% |
Neuroscience | 3 | 5% |
Other | 1 | 2% |
Unknown | 11 | 20% |